On May 24, 2024 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, reported that senior leadership plans to present at the following conferences and events (Press release, Iovance Biotherapeutics, MAY 24, 2024, View Source [SID1234643678]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 5th Annual Oncology Innovation Summit: Insights for ASCO (Free ASCO Whitepaper) & EHA (Free EHA Whitepaper)
Fireside Chat: May 28, 2024 at 3:00 p.m. ET
Virtual
Iovance ASCO (Free ASCO Whitepaper) Investor/Analyst Event
Presentation and Key Opinion Leader Panel Discussion: May 31, 2024 at 7:15 p.m. ET
Chicago, IL and Virtual
Jefferies Global Healthcare Conference
Fireside Chat: June 6, 2024 at 9:30 a.m. ET
New York, NY
Goldman Sachs Global Healthcare Conference
Fireside Chat: June 10, 2024 at 2:40 p.m. ET
Miami, FL
Iovance 2024 Annual Meeting
June 11, 2024 at 11:00 a.m. ET
Virtual
The live and archived webcasts will be available at View Source